David Windley
Stock Analyst at Jefferies
(3.67)
# 686
Out of 4,853 analysts
191
Total ratings
67.89%
Success rate
13.69%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STE STERIS | Initiates: Hold | $263 | $243.58 | +7.97% | 1 | May 29, 2025 | |
| SLQT SelectQuote | Initiates: Hold | $2.75 | $2.15 | +27.91% | 1 | May 21, 2025 | |
| CNC Centene | Maintains: Hold | $64 → $61 | $54.84 | +11.23% | 28 | Apr 29, 2025 | |
| OSCR Oscar Health | Initiates: Underperform | $12 | $15.65 | -23.32% | 1 | Dec 10, 2024 | |
| HUM Humana | Downgrades: Hold | $419 → $253 | $227.16 | +11.38% | 18 | Oct 7, 2024 | |
| FTRE Fortrea Holdings | Downgrades: Hold | $25 → $21 | $5.14 | +308.96% | 2 | Sep 25, 2024 | |
| MEDP Medpace Holdings | Downgrades: Hold | $415 → $345 | $293.58 | +17.51% | 5 | Sep 25, 2024 | |
| CI The Cigna Group | Maintains: Buy | $402 → $422 | $311.02 | +35.68% | 17 | Sep 17, 2024 | |
| MOH Molina Healthcare | Maintains: Hold | $354 → $297 | $293.56 | +1.17% | 23 | Jul 24, 2024 | |
| IQV IQVIA Holdings | Downgrades: Hold | $266 → $242 | $147.37 | +64.21% | 4 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $481 → $647 | $295.84 | +118.70% | 26 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $12 → $3.75 | $2.71 | +38.38% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $602 → $604 | $384.65 | +57.03% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $558.06 | -32.80% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $12.18 | +27.31% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $289.94 | -6.88% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $11.71 | +32.37% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $218.58 | +145.22% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $23.24 | +24.78% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $233 → $203 | $141.20 | +43.77% | 19 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $276 → $302 | $134.82 | +124.00% | 14 | Sep 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $6.93 | +3,478.64% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.50 | - | 5 | Oct 9, 2017 |
STERIS
May 29, 2025
Initiates: Hold
Price Target: $263
Current: $243.58
Upside: +7.97%
SelectQuote
May 21, 2025
Initiates: Hold
Price Target: $2.75
Current: $2.15
Upside: +27.91%
Centene
Apr 29, 2025
Maintains: Hold
Price Target: $64 → $61
Current: $54.84
Upside: +11.23%
Oscar Health
Dec 10, 2024
Initiates: Underperform
Price Target: $12
Current: $15.65
Upside: -23.32%
Humana
Oct 7, 2024
Downgrades: Hold
Price Target: $419 → $253
Current: $227.16
Upside: +11.38%
Fortrea Holdings
Sep 25, 2024
Downgrades: Hold
Price Target: $25 → $21
Current: $5.14
Upside: +308.96%
Medpace Holdings
Sep 25, 2024
Downgrades: Hold
Price Target: $415 → $345
Current: $293.58
Upside: +17.51%
The Cigna Group
Sep 17, 2024
Maintains: Buy
Price Target: $402 → $422
Current: $311.02
Upside: +35.68%
Molina Healthcare
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $293.56
Upside: +1.17%
IQVIA Holdings
Jul 24, 2024
Downgrades: Hold
Price Target: $266 → $242
Current: $147.37
Upside: +64.21%
Jul 17, 2024
Upgrades: Buy
Price Target: $481 → $647
Current: $295.84
Upside: +118.70%
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $2.71
Upside: +38.38%
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $384.65
Upside: +57.03%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $558.06
Upside: -32.80%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $12.18
Upside: +27.31%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $289.94
Upside: -6.88%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $11.71
Upside: +32.37%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $218.58
Upside: +145.22%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $23.24
Upside: +24.78%
Mar 28, 2023
Maintains: Hold
Price Target: $233 → $203
Current: $141.20
Upside: +43.77%
Sep 14, 2021
Maintains: Buy
Price Target: $276 → $302
Current: $134.82
Upside: +124.00%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $6.93
Upside: +3,478.64%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.50
Upside: -